459 related articles for article (PubMed ID: 29755452)
21. Complete Genome Sequencing of Influenza A Viruses within Swine Farrow-to-Wean Farms Reveals the Emergence, Persistence, and Subsidence of Diverse Viral Genotypes.
Diaz A; Marthaler D; Culhane M; Sreevatsan S; Alkhamis M; Torremorell M
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659482
[TBL] [Abstract][Full Text] [Related]
22. Understanding immunity to influenza: implications for future vaccine development.
Tripp RA
Expert Rev Vaccines; 2023; 22(1):871-875. PubMed ID: 37794732
[TBL] [Abstract][Full Text] [Related]
23. Animal Models for Influenza A Virus Infection Incorporating the Involvement of Innate Host Defenses: Enhanced Translational Value of the Porcine Model.
Starbæk SMR; Brogaard L; Dawson HD; Smith AD; Heegaard PMH; Larsen LE; Jungersen G; Skovgaard K
ILAR J; 2018 Dec; 59(3):323-337. PubMed ID: 30476076
[TBL] [Abstract][Full Text] [Related]
24. Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.
Hayashi T; MacDonald LA; Takimoto T
J Virol; 2015 Jun; 89(12):6442-52. PubMed ID: 25855745
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
Nacken W; Ehrhardt C; Ludwig S
Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
[TBL] [Abstract][Full Text] [Related]
26. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.
Nogales A; DeDiego ML; Martínez-Sobrido L
Front Cell Infect Microbiol; 2022; 12():954811. PubMed ID: 35937688
[TBL] [Abstract][Full Text] [Related]
27. Influenza Virus Infections and Cellular Kinases.
Meineke R; Rimmelzwaan GF; Elbahesh H
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791550
[TBL] [Abstract][Full Text] [Related]
28. Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview.
Mostafa A; Abdelwhab EM; Mettenleiter TC; Pleschka S
Viruses; 2018 Sep; 10(9):. PubMed ID: 30217093
[TBL] [Abstract][Full Text] [Related]
29. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
30. Host Immune Response to Influenza A Virus Infection.
Chen X; Liu S; Goraya MU; Maarouf M; Huang S; Chen JL
Front Immunol; 2018; 9():320. PubMed ID: 29556226
[TBL] [Abstract][Full Text] [Related]
31. Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.
Driver JP; de Carvalho Madrid DM; Gu W; Artiaga BL; Richt JA
Front Immunol; 2020; 11():2172. PubMed ID: 33193296
[TBL] [Abstract][Full Text] [Related]
32. Evasion of influenza A viruses from innate and adaptive immune responses.
van de Sandt CE; Kreijtz JH; Rimmelzwaan GF
Viruses; 2012 Sep; 4(9):1438-76. PubMed ID: 23170167
[TBL] [Abstract][Full Text] [Related]
33. Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein.
Beyleveld G; Chin DJ; Moreno Del Olmo E; Carter J; Najera I; Cillóniz C; Shaw ML
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429226
[TBL] [Abstract][Full Text] [Related]
34. Structure and Function of the Influenza A Virus Non-Structural Protein 1.
Han CW; Jeong MS; Jang SB
J Microbiol Biotechnol; 2019 Aug; 29(8):1184-1192. PubMed ID: 31154753
[TBL] [Abstract][Full Text] [Related]
35. Interplay between influenza A virus and host factors: targets for antiviral intervention.
Tripathi S; Batra J; Lal SK
Arch Virol; 2015 Aug; 160(8):1877-91. PubMed ID: 26016443
[TBL] [Abstract][Full Text] [Related]
36. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
Zhou A; Dong X; Liu M; Tang B
Front Immunol; 2021; 12():632798. PubMed ID: 34367124
[TBL] [Abstract][Full Text] [Related]
38. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
39. Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.
Khalil AM; Nogales A; Martínez-Sobrido L; Mostafa A
Front Cell Infect Microbiol; 2024; 14():1357866. PubMed ID: 38375361
[TBL] [Abstract][Full Text] [Related]
40. Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.
Alymova IV; York IA; McCullers JA
PLoS One; 2014; 9(11):e111603. PubMed ID: 25368997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
